LENZ Therapeutics Inc. (LENZ) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    LENZ Therapeutics Inc.

    NASDAQ: LENZ · Real-Time Price · USD
    39.63
    -2.35 (-5.60%)
    At close: Sep 08, 2025, 3:59 PM
    40.59
    2.42%
    After-hours: Sep 08, 2025, 06:39 PM EDT

    LENZ Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -49.77M -69.97M -101.05M -70.76M
    Depreciation & Amortization
    		 58K 15K 8.35M 734K
    Stock-Based Compensation
    		 6.37M 1.34M 721K 196K
    Other Working Capital
    		 -8.81M 8.55M -7.4M -4.32M
    Other Non-Cash Items
    		 -2.95M -1.18M 11.93M 19.32M
    Deferred Income Tax
    		 n/a n/a n/a 161K
    Change in Working Capital
    		 -13.09M 9.41M -7.21M -2.5M
    Operating Cash Flow
    		 -59.39M -60.38M -87.98M -52.85M
    Capital Expenditures
    		 -468K -30K -6.59M -5.74M
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 -241.91M -52.09M -405.52M n/a
    Sales Maturities Of Investments
    		 87.9M 22.5M 170.25M n/a
    Other Investing Acitivies
    		 n/a 1.9M n/a n/a
    Investing Cash Flow
    		 -154.48M -29.62M -241.86M -5.74M
    Debt Repayment
    		 n/a n/a n/a n/a
    Common Stock Repurchased
    		 n/a -67K -79K n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 119.49M -2.28M 129K 306K
    Financial Cash Flow
    		 199M 80.7M 597K 417.47M
    Net Cash Flow
    		 -14.87M -9.3M -329.25M 357.16M
    Free Cash Flow
    		 -59.86M -60.41M -94.57M -58.59M

    Add to Watchlist